EW

Edwards Lifesci

NYSE

Real-time Quotes | Nasdaq Last Sale

109.52

-4.97

-4.34%

Closed 16:00 11/26 EST

OPEN

114.14

PREV CLOSE

114.49

HIGH

114.86

LOW

109.25

VOLUME

2.25M

TURNOVER

52 WEEK HIGH

123.27

52 WEEK LOW

78.44

MARKET CAP

68.38B

P/E (TTM)

46.93

Edwards Lifesciences (NYSE:EW) shareholders have earned a 33% CAGR over the last five years

For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality...

Simply Wall St. · 6d ago

EULAV Asset Management Buys Edwards Lifesciences Corp, Exact Sciences Corp, Delta Air Lines ...

GuruFocus News · 11/16 18:38

Tri Locum Partners LP Buys Baxter International Inc, Seagen Inc, Merck Inc, Sells Regeneron ...

GuruFocus News · 11/16 13:38

WealthShield Partners, LLC Buys Vanguard Mega Cap Growth ETF, Invesco Dynamic Semiconductors ...

GuruFocus News · 11/12 22:38

Bluestein R H & Co Buys Palo Alto Networks Inc, Spotify Technology SA, Xylem Inc, Sells ...

GuruFocus News · 11/12 21:38

Brown Advisory Securities, LLC Buys Ameriprise Financial Inc, Chubb, Target Corp, Sells Amazon. ...

GuruFocus News · 11/12 19:38

Marvin & Palmer Associates Inc Buys Intuitive Surgical Inc, Edwards Lifesciences Corp, ...

GuruFocus News · 11/12 14:38

Here's Why You Should Retain Edwards Lifesciences (EW) Stock

Zacks.com · 11/12 13:33

Forecast

Actual (USD)

Estimate (USD)

Income StatementMore

Net Income (USD)

YoY (%)

Balance SheetMore

Total Assets (USD)

Total Liabilities (USD)

Debt to Asset (%)

Cash FlowMore

Operating (USD)

YoY (%)

Learn about the latest financial forecast of EW. Analyze the recent business situations of Edwards Lifesci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.

Analyst Rating

Based on 25 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

24.00%Strong Buy

28.00%Buy

44.00%Hold

0.00%Under-perform

4.00%Sell

Analyst Price Target

The average EW stock price target is 120.65 with a high estimate of 135.00 and a low estimate of 71.00.

High135.00

Average120.65

Low71.00

Current 109.52

EPS

Actual

Estimate

0.160.320.480.64

Q4 2020

Q1 2021

Q2 2021

Q3 2021

Q4 2021

Institutional Holdings

Institutions: 1.53K

Institutional Holdings: 551.01M

% Owned: 88.26%

Shares Outstanding: 624.33M

TypeInstitutionsShares

Increased

426

18.87M

New

116

4.00M

Decreased

399

16.40M

Sold Out

2.71M

Performance
Asset Allocation
Dividend History

No Data

Industry

Advanced Medical Equipment & Technology

-0.02%

Healthcare Equipment & Supplies

-0.85%

Key Executives

Chairman/Director/Chief Executive Officer

Michael Mussallem

Chief Financial Officer/Vice President

Scott Ullem

Corporate Executive

Jean-Luc Lemercier

Vice President

Donald Bobo

Vice President

Daveen Chopra

Vice President

Catherine Szyman

Vice President

Huimin Wang

Vice President

Larry Wood

Lead Director/Independent Director

Martha Marsh

Independent Director

Kieran Gallahue

Independent Director

Leslie Heisz

Independent Director

Paul LaViolette

Independent Director

Steven Loranger

Independent Director

Ramona Sequeira

Independent Director

Nicholas Valeriani

No Data

All
Financials
Insiders

About EW

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

Webull offers kinds of Edwards Lifesciences Corp stock information, including NYSE:EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.